Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 248 768 M
EBIT 2018 -
Net income 2018 38 223 M
Finance 2018 140 495 M
Yield 2018 1,90%
Sales 2019 271 296 M
EBIT 2019 -
Net income 2019 44 623 M
Finance 2019 150 024 M
Yield 2019 1,95%
P/E ratio 2018 34,44
P/E ratio 2019 27,68
EV / Sales2018 5,29x
EV / Sales2019 4,81x
Capitalization 1 455 711 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
07/20 ONO PHARMACEUTICAL : Patent Issued for Therapeutic Agent for Autoimmune Diseases..
07/18 ONO PHARMACEUTICAL : Support for Relief Efforts to the Northern Kyushu Heavy Rai..
07/14 ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of S..
07/13 ONO PHARMACEUTICAL : Second Phase III Study Shows Kyprolis® (Carfilzomib) Regime..
07/06 ONO PHARMACEUTICAL : Array BioPharma Submits New Drug Applications to FDA for Bi..
07/06 ONO PHARMACEUTICAL : Phase 3 Study Evaluating the Safety and Efficacy of Adjuvan..
06/29 ONO PHARMACEUTICAL : Patent Issued for Left Ventricular Diastolic Function Impro..
06/29 ONO PHARMACEUTICAL : Notice of Resolutions Passed at The 69th Ordinary General S..
06/29 ONO PHARMACEUTICAL : Notice Concerning Issuance of Stock Options (Stock Acquisit..
06/19 ONO PHARMACEUTICAL : Extended Follow-Up Data Evaluating Opdivo (nivolumab) Shows..
More news
Sector news : Generic Pharmaceuticals
07/21 FTSE, sheltered from euro strength, has best week since May
07/21DJGLAXOSMITHKLINE : FDA Approves Injectable Form Of Glaxo's Benlysta
07/21 GlaxoSmithKline's new CEO prepares to trim drug pipeline
07/21 AstraZeneca CEO reassures staff, aims to be at September cancer meet
07/20 Abbott profit forecast gets a lift from St. Jude integration
More sector news : Generic Pharmaceuticals
Latest Tweets
06/29ONO PHARMACEUTICAL : Notice of Resolutions Passed at The 69th Ordinary Genera.. 
06/29ONO PHARMACEUTICAL : Notice Concerning Issuance of Stock Options (Stock Acqui.. 
06/13ONO PHARMACEUTICAL : Announcement on Acquisition and Retirement of Own Shares.. 
05/31$ARRY (+3.1% pre) Array BioPharma & Ono Pharmaceutical Announce A License..
2
05/31BRIEF-Ono Pharmaceutical concludes a license agreement with array biopharma r.. 
More tweets
Qtime:23
News from SeekingAlpha
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/02 3 THINGS IN BIOTECH YOU SHOULD LEARN : June 2, 2017
05/31 Array out-licenses binimetinib and encorafenib to Ono Pharma for Japan and So..
05/10 BRISTOL-MYERS SQUIBB : A Deep Dive Finds Some Pearls
01/23 Bristol Catches A Break At Last
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 2 629  JPY
Spread / Average Target 6,4%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Shozo Matsuoka Executive Officer & Manager-Medical Affairs
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
Sector and Competitors